Recruiting Mantle Cell Lymphoma Studies in Rochester
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
This phase II trial tests how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has come back (after a period of improvement) (relapsed) or that ha...
GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
Primary Objectives: To estimate the percent of participants who achieve a best response of complete response by the end of the PRV combination therapy in the induction therapy phase in patients with ...
About Mantle Cell Lymphoma Clinical Trials in Rochester
Mantle cell lymphoma (MCL) is a rare, aggressive type of non-Hodgkin lymphoma that develops from B-cells in the mantle zone of lymph nodes. It accounts for about 5-7% of all NHL cases. Treatment includes combination chemotherapy, targeted therapy, and stem cell transplant.
There are currently 2 mantle cell lymphoma clinical trials recruiting participants in Rochester, MINNESOTA. These studies are seeking a combined 140 participants. Research is being sponsored by Academic and Community Cancer Research United, M.D. Anderson Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Mantle Cell Lymphoma Clinical Trials in Rochester — FAQ
Are there mantle cell lymphoma clinical trials in Rochester?
Yes, there are 2 mantle cell lymphoma clinical trials currently recruiting in Rochester, MINNESOTA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Rochester?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.
Are clinical trials in Rochester free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.
What mantle cell lymphoma treatments are being tested?
The 2 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for mantle cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov